Abstract: Folding apparatus (1) for folding sheet packaging elements (2), comprising main conveying means (12), configured to sequentially receive the packaging elements (2) from a feeding station (13) and to advance each packaging element (2) along a first path (A), forming means (15), carried by the main conveying means (12) and configured to cooperate in use with a first face (2b) of each packaging element (2) while the packaging element (2) is advanced along the first path (A), and folding means (18), advanced by auxiliary conveying means (16) along a second path (Q), having a first portion (Q1) distinct from the first path (A) and a second portion (Q2), which is in common with the first path (A) and along which the folding means (18) cooperate with a second face (2a), opposite the first face (2b), of each packaging element (2) to fold the packaging element (2) against the forming means (15).

Abstract: There is described a magazine (1) for sheet packaging elements (2) in which side portions (4a) of said packaging elements (2) are held in a vertical position by transport and support branches (15, 18, 20) of main and secondary units (6, 8, 9) and said packaging elements (2) are advanced in respective conveying spaces (16, 19, 21) along a path (P) parallel to said transport and support branches (15, 18, 20) of said main and secondary units (6, 8, 9). The packaging elements (2) are advanced along said path (P) from an inlet section (7) to an outlet section (12). During conveying, batches (3) of packaging elements (2) are formed between an accumulation unit (8) and an auxiliary conveying unit (9) so that said packaging elements (2) are advanced in said batches (3) towards an end packaging station.

Abstract: There is described a magazine (1) for sheet packaging elements (2) in which side portions (4a) of said packaging elements (2) are held in a vertical position by transport and support branches (15, 18, 20) of main and secondary units (6, 8, 9) and said packaging elements (2) are advanced in respective conveying spaces (16, 19, 21) along a path (P) parallel to said transport and support branches (15, 18, 20) of said main and secondary units (6, 8, 9). The packaging elements (2) are advanced along said path (P) from an inlet section (7) to an outlet section (12). During conveying, batches (3) of packaging elements (2) are formed between an accumulation unit (8) and an auxiliary conveying unit (9) so that said packaging elements (2) are advanced in said batches (3) towards an end packaging station.

Abstract: Folding apparatus (1) for folding sheet packaging elements (2), comprising main conveying means (12), configured to sequentially receive the packaging elements (2) from a feeding station (13) and to advance each packaging element (2) along a first path (A), forming means (15), carried by the main conveying means (12) and configured to cooperate in use with a first face (2b) of each packaging element (2) while the packaging element (2) is advanced along the first path (A), and folding means (18), advanced by auxiliary conveying means (16) along a second path (Q), having a first portion (Q1) distinct from the first path (A) and a second portion (Q2), which is in common with the first path (A) and along which the folding means (18) cooperate with a second face (2a), opposite the first face (2b), of each packaging element (2) to fold the packaging element (2) against the forming means (15).

Abstract: Compositions for inhibiting the corrosion of metals in contact with an aqueous system are provided. The corrosion inhibiting compositions may be used to maintain effective amounts of (1) an amino acid-based polymer, such as a polyaspartic acid compound, and (2) a dispersible and/or soluble tin compound in the aqueous system. The corrosion inhibiting compositions include the amino acid-based polymer and a dispersible and/or soluble tin compound and may optionally include a polycarboxylic acid chelating agent and/or a carboxylate/sulfonate functional copolymer.

Abstract: Methods for inhibiting the corrosion of metals in contact with an aqueous system are provided. The method of inhibiting corrosion includes maintaining effective amounts of (1) an amino acid-based polymer, such as a polyaspartic acid compound, and (2) a dispersible and/or soluble tin compound in the aqueous system. The corrosion inhibiting components of the treatment may be added simultaneously or separately into the water of the aqueous system, i.e., provided either in a single treatment product or as separate products. Such a corrosion inhibiting method may optionally also include adding a polycarboxylic acid chelating agent and/or a carboxylate/sulfonate functional copolymer to the aqueous system.

Abstract: Compositions for inhibiting the corrosion of metals in contact with an aqueous system are provided. The corrosion inhibiting compositions may be used to maintain effective amounts of (1) an amino acid-based polymer, such as a polyaspartic acid compound, and (2) a dispersible and/or soluble tin compound in the aqueous system. The corrosion inhibiting compositions include the amino acid-based polymer and a dispersible and/or soluble tin compound and may optionally include a polycarboxylic acid chelating agent and/or a carboxylate/sulfonate functional copolymer.

Abstract: Compositions and methods for inhibiting the corrosion of metals in contact with an aqueous system are provided. The method of inhibiting corrosion includes maintaining effective amounts of (1) an amino acid-based polymer, such as a polyaspartic acid compound, and (2) a dispersible and/or soluble tin compound in the aqueous system. The corrosion inhibiting components of the treatment may be added simultaneously or separately into the water of the aqueous system, i.e., provided either in a single treatment product or as separate products. The single treatment single treatment product may include the amino acid-based polymer and a dispersible and/or soluble tin compound. Such a corrosion inhibiting composition may optionally also include a polycarboxylic acid chelating agent and/or a carboxylate/sulfonate functional copolymer.

Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for causing immunosuppression. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing an autoimmune disease.

Abstract: This invention provides 7-deoxy-taxol analogs of Formula I: The compounds of Formula I (including II and III) are useful for the same cancers for which taxol has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia.

Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.

Abstract: Pollution from industrial plants which produce NO.sub.x and waste water is reduced by utilizing waste water to prepare aqueous NO.sub.x -reducing solutions. Total water hardness in the waste water is preferably maintained below 2500 ppm, silicate below 200 ppm and the calcium to magnesium ratio above 2:1. The aqueous NO.sub.x -reducing solution will preferably contain hardness suppressing compostions in effective amounts.

Abstract: This invention provides a new use of acids, esters, and salts of arylmethylphosphonates of Formula I, ##STR1## or a phosphonic acid of Formula II ##STR2## and derivatives as anti-inflammatory and anti-arthritic agents. Representative compounds include 4-dodecyloxybenzylphosphonic acid dimethyl ester, (2-naphthalenylmethyl)phosphonic acid dimethyl ester, and ([1,1'-biphenyl]-2-ylmethyl)phosphonic acid dimethyl ester.

Abstract: A business form having an integrated label in its top ply or other sheets advantageously includes a release sheet which is only partially covered with a release coating in order to provide a controlled release. The controlled release is provided by skiving lines which preferably remove a portion of the release coating within a border on the release sheet. The adhesive layer is thereby directly connected to both the label and the release sheet. The release coating is penetrated intermittently by the skiving lines to remove a portion of the release coating. Alternatively, a pattern of release coating of silicone or the like may be printed in a pattern so that the release coating is only intermittently provided in covering relationship over the release sheet. The provision of intermittent direct contact between the adhesive and the release sheet provides improved adhesion of the label to the liner without detracting from the functionality of the form or the label.

Abstract: This invention provides 7-deoxy-.DELTA..sup.6,7 -taxol and 7-deoxy-.DELTA..sup.6,7 -taxol analogs of Formula I: ##STR1## The compounds of Formula I are useful for the same cancers for which taxol has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia.